Tempest Therapeutics, Inc. Common Stock (TPST) is a publicly traded Healthcare sector company. As of July 15, 2026, TPST trades at $1.00 with a market cap of $15.72M and a P/E ratio of -0.15. TPST moved +1.58% today. Year to date, TPST is -31.67%; over the trailing twelve months it is -71.58%. Its 52-week range spans $0.94 to $6.83. Rallies surfaces TPST's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Tempest Therapeutics, Inc. Common Stock (TPST) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. TPST moved +1.58% today.
| Metric | Value |
|---|---|
| Price | $1.00 |
| Market Cap | $15.72M |
| P/E Ratio | -0.15 |
| EPS | $-6.33 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.83 |
| 52-Week Low | $0.94 |
| Volume | 27.80K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-26.26M |
| Gross Margin | 0.00% |
TPST analyst coverage data. Average price target: $0.00.